Innovative Medical Device BlueWind Medical specializes in minimally invasive neuromodulation solutions for urge urinary incontinence, presenting opportunities to partner with healthcare providers seeking advanced, patient-centric therapies.

Recent Market Entry The launch of their Revi implantable tibial neuromodulation device in Louisiana indicates a growing market presence and potential for expansion into additional regions and clinical settings.

Strong Financial Backing With a recent Series B funding of $64 million led by ConvaTec, BlueWind Medical has significant capital to support product development, sales channels, and strategic partnerships in the continence care market.

Experienced Leadership The appointment of key industry professionals such as Lori Chmura as Chair and Liz Kwo to the board supports strategic growth and enhances credibility when engaging with healthcare institutions and stakeholders.

Growing Industry Recognition Since developing the iTNM technology in 2010, BlueWind Medical has evolved into an established player in neuromodulation therapy, providing opportunities to introduce complementary technologies and expanded solutions to existing client bases.